Exact Sciences (EXAS) Reports Prelim Q4 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Exact Sciences (EXAS) Reports Prelim Q4 Results

Exact Sciences Announces Preliminary Fourth Quarter 2023 Results

January 7, 2024 4:30 PM EST

Anticipates record fourth-quarter revenue, expects full-year 2024 revenue of $2.83 billion, submits next-generation Cologuard® to FDA

Announces Chief Financial Officer succession plan

Highlighted announcements:

Expects total fourth quarter revenue of $645.5-$647.5 million, an increase of 17% compared to the fourth quarter of 2022, with Screening revenue of $486.0-$487.0 million and Precision Oncology revenue of $159.5-$160.5 millionExpects total full-year 2023 revenue of $2.50 billion and 2024 revenue of $2.83 billionSubmitted final module of next-generation Cologuard premarket... More